falsefalse

Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care - Episode 13

Future of MF

, , , ,

Experts discuss how treatments, either monotherapy or combination, may impact the treatment landscape for MF and how they might choose among the new agents.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Diagnosing Polycythemia Vera (PV)
    EP. 2: Polycythemia Vera: Assessing Risk and Genetic Testing
    EP. 3: Polycythemia Vera: Treatment Goals and Options
    EP. 4: REVEAL Study: Clinical Implications
    EP. 5: Polycythemia Vera: Choosing the Right Treatment
    EP. 6: MAJIC-PV: Clinical Implications in PV
    EP. 7: Role of Transplant in Myelofibrosis
    EP. 8: Myelofibrosis: FDA Approved Treatment Options and Updates from ASH 2023
    EP. 9: Treating Patients with Myelofibrosis and Anemia
    EP. 10: Monitoring Patients on Myelofibrosis Treatment
    EP. 11: Future of PV: Unmet Needs
    EP. 12: Combination Therapies for MF Management
    Now Viewing
    EP. 13: Future of MF

    Related Content:

    Polycythemia Vera and Myelofibrosis: Current and Future Standards of CareMyeloproliferative NeoplasmsHematologic Oncology
    Dr Orgueira on the Use of Machine Learning to Predict Survival Outcomes After Allo-HSCT in Myelofibrosis
    Bexmarilimab Plus Azacitidine Meets ORR End Point in R/R Higher-Risk MDS
    Dr Hernández-Boluda on the Rationale for Using Machine Learning to Predict Post-HCT Outcomes in Myelofibrosis
    x